1321. 4.O. Workshop: Using data to save lives in times of COVID-19 and beyond. (20th October 2021) Authors: Journal: European journal of public health Issue: Volume 31(2021)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1322. 4.P. Workshop: Health promotion policy implementation evaluation: tools, challenges and futures directions. (25th October 2022) Authors: Journal: European journal of public health Issue: Volume 32(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1323. 4.Q. Workshop: Intersex human rights and wellbeing - Part II: From ethics to healthcare approaches and policies. (20th October 2021) Authors: Journal: European journal of public health Issue: Volume 31(2021)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1324. 4.Q. Workshop: Showcasing PHIRI use case results measuring the impact of COVID-19 on population health. (25th October 2022) Authors: Journal: European journal of public health Issue: Volume 32(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1325. 40. Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial. (4th December 2021) Authors: Temesgem, Zelalem; Burger, Charles; Baker, Jason; Polk, Christopher; Libertin, Claudia R; Kelley, Colleen F; Marconi, Vincent; Orenstein, Robert; Catterson, Victoria; Aronstein, William; Durrant, Cameron; Chappell, Dale; Ahmed, Omar; Chappell, Gabrielle; Badley, Andrew Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1326. 4054Betablockers and outcomes in stable coronary artery disease. Insights from the CLARIFY registry. (28th August 2018) Authors: Sorbets, E; Young, R; Danchin, N; Greenlow, N; Ford, I; Tendera, M; Ferrari, R; Tardif, J C; Fox, K M; Steg, P G Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1327. 4057Beta-blockers in ST elevation myocardial infarction patients with reduced, mid-range, and preserved ejection fraction: the same benefit?. (28th August 2018) Authors: Nobre De Matos Pereira Vieira, M J; Durao, D; Belo, A; Domingues, K; Craveiro, N; Saraiva, M; Saldanha Santos, B; Alves, M; Leal, M Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1328. 4061One year survival benefit of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in acute coronary syndrome undergoing PCI according to left ventricular ejection fraction. (28th August 2018) Authors: Cespon Fernandez, M; Raposeiras Roubin, S; Abu-Assi, E; Munoz Pousa, I; Cobas Paz, R; Caneiro Queija, B; Fernandez Barbeira, S; Dascenzo, F; Simao Henriques, J P; Calvo Iglesias, F; Iniguez Romo, A Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1329. 4064Effects of chronic kidney disease on clinical outcomes in patients with peripheral artery disease undergoing endovascular treatment: analysis from the K-VIS ELLA registry. (28th August 2018) Authors: Kim, W; Kim, H O; Cho, J H; Kim, J M; Chung, H M Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
1330. 4065Moderate to severe renal insufficiency and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: the EUCLID trial. (28th August 2018) Authors: Hopley, C W; Kavanagh, S; Patel, M; Baumgartner, I; Berger, J S; Blomster, J I; Fowkes, F G R; Jones, W S; Katona, B G; Mahaffey, K W; Norgren, L; Held, P; Rockhold, F W; Hiatt, W R Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗